|
Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies |
|
|
|
Title: |
Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies |
Author: |
Peyrin-Biroulet, Laurent Colombel, Jean-Frederic Louis, Edouard Ferrante, Marc Motoya, Satoshi Panaccione, Remo Torres, Joana Ungaro, Ryan C. Kligys, Kristina Kalabic, Jasmina Zambrano, Javier Zhang, Yafei D'Haens, Geert |
Appeared in: |
Gastro Hep advances |
Paging: |
Volume 3 () nr. 4 pages 539-550 |
Year: |
2024 |
Contents: |
|
Publisher: |
Published by Elsevier B.V. |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|